Unified Program Integrity Contractors review ophthalmology and optometry claims concentrated on diagnostic imaging frequency, intravitreal injection billing, and cataract and glaucoma surgical volume. A single flagged testing pattern across optical coherence tomography and visual field claims can trigger a full-practice lookback, a recoupment demand built on extrapolation, and a referral where the documentation does not support the billing. Eye care practices that bill high volumes of diagnostic testing alongside surgical and injection codes sit inside this review pattern, where the record each claim leaves behind decides whether the claim survives.
Diagnostic Imaging and Visual Field Testing Frequency
Medicare coverage policy for optical coherence tomography and other scanning ophthalmic diagnostic imaging excludes screening use outright. The test must evaluate a documented retinal or optic nerve finding, not establish one absent any clinical indication. Coverage policy for glaucoma management anticipates a limited number of imaging exams per eye each year, with additional testing reserved for documented disease progression or treatment response. When imaging and visual field testing are billed on the same date, or within a short interval of each other, the record must state why both were medically necessary rather than duplicative. UPIC reviewers pull the ordering physician's note alongside the test result and interpretation. A scanned report with no corresponding clinical finding, no comparison to the prior test, and no documented reason for the interval is the pattern that drives a recoupment demand across the full lookback period.
In eye care audits, SCODI coverage turns on whether the indication is documented, not on whether the decision to order the test was sound.
Intravitreal Injection Claims Under Review
Intravitreal anti-VEGF injections carry their own documentation chain, separate from the general injectable drug billing issues HLA addresses in UPIC Audits of Infusion and Injection Drug Claims. Coverage policy requires the diagnostic test results, optical coherence tomography or fluorescein angiography, that establish the diagnosis being treated, along with the dosage, site, and route of administration. Each injection claim must carry the site modifier identifying which eye received it. A chart with monthly injection claims but no interval re-examination, no updated imaging, and no documented treatment response reads as a billing pattern rather than ongoing medical management, and that distinction is where the audit finding gets written.
Cataract and Glaucoma Surgical Documentation
Coverage policy conditions cataract surgery's medical necessity on documented functional impairment, difficulty reading, driving, watching television, or meeting occupational demands, that glasses or other non-surgical correction cannot resolve, with visual acuity considered in that context rather than as a standalone threshold. Borderline cases draw on glare testing or contrast sensitivity results to support the impairment finding. Complex cataract surgery claims carry their own test: a miotic pupil requiring a mechanical iris expansion device, pre-existing zonular weakness, or another documented complicating factor tied to the patient's anatomy, rather than a surgeon's preference for a particular technique. Glaucoma procedures reviewed alongside cataract claims are judged against the same imaging and visual field series discussed above. A surgical decision without a documented progression pattern across prior tests is the gap a UPIC reviewer flags first.
Routine Vision Services Versus Medically Necessary Eye Care
Medicare's exclusion for routine eye examinations and refractive services runs alongside its coverage of medically necessary diagnosis and treatment of eye disease, and the line between the two is where mixed-service visits draw scrutiny. A visit billed as a medically necessary eye examination needs a documented disease-related reason for the visit, not a routine refraction billed under a disease code because a patient also needed new glasses. A diagnostic test performed by a technician must be ordered by the treating physician who uses the results to manage the patient's problem, and where that physician's signature on the order or interpretation is illegible, a signature log identifying the name behind it is what resolves the ambiguity. Medicare's program integrity rules let a reviewer pursue a denial when a signature issue is not otherwise resolved.
It is critical that ophthalmology and optometry practices promptly retain experienced healthcare defense counsel upon receiving a UPIC document request, audit notice, or other government inquiry. Early legal intervention can protect the practice's rights, shape the record before it is submitted, and prevent an extrapolated finding from calcifying into a referral. A pattern that looks like billing error to a UPIC reviewer can escalate into a fraud referral, including a target letter naming an individual as its target. Delaying representation narrows the options available once that referral is made.
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
We represent ophthalmology and optometry practices through every stage of a UPIC review, from the initial document request through appeal, and build the medical-necessity record a reviewer's extrapolation depends on. If your practice has received a UPIC request tied to imaging, injection, or surgical claims, contact us for a free, confidential consultation before you respond.





